Patrick Cherubin
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Endocrinology top 10%
- Escherichia coli research studies
Papers in
-
- Toxin Mechanisms and Immunotoxins 7
-
- Transgenic Plants and Applications 5
- Microbial Inactivation Methods 2
- Co-authors
- Ken Teter (10 shared papers)Paul Bates (1 shared paper)Michael J. Hogan (1 shared paper)Florian Krammer (1 shared paper)Katlyn Lederer (1 shared paper)Diana Castaño (1 shared paper)Drew Weissman (1 shared paper)Thomas H. Oguin (1 shared paper)
- Journals
- PLoS ONE (2 papers)Scientific Reports (2 papers)Immunity (1 paper)Infection and Immunity (1 paper)Bioscience Reports (1 paper)
- Partner nations
- United StatesNorwayGermany
In The Last Decade
Patrick Cherubin
12 papers receiving 383 citations
Patrick Cherubin's Hit Papers
Peers
Comparison fields: 5 of 66
- Infectious Diseases 176
- Endocrinology 43
- Immunology 124
- Animal Science and Zoology 27
- Biotechnology 22
Countries citing papers authored by Patrick Cherubin
This map shows the geographic impact of Patrick Cherubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Cherubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Cherubin more than expected).
Fields of papers citing papers by Patrick Cherubin
This network shows the impact of papers produced by Patrick Cherubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Cherubin. The network helps show where Patrick Cherubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Cherubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation Hit paper breakdown → | 2020 | 240 |
| 2 | 2015 | 31 | |
| 3 | 2016 | 30 | |
| 4 | 2013 | 24 | |
| 5 | 2018 | 14 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 9 | |
| 8 | 2018 | 9 | |
| 9 | 2019 | 9 | |
| 10 | 2017 | 6 | |
| 11 | 2019 | 5 | |
| 12 | The Anti-toxin Properties of Grape Seed Phenolic Compounds | 2014 | 1 |
| 13 | 2022 | 0 |
About Patrick Cherubin
Patrick Cherubin is a scholar working on Immunology, Biotechnology, Endocrinology, Infectious Diseases and Molecular Biology, having authored 13 papers that have together received 388 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (5 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Vibrio bacteria research studies (3 papers), Escherichia coli research studies (3 papers), Microbial Inactivation Methods (2 papers), Bacteriophages and microbial interactions (2 papers) and Phytochemicals and Antioxidant Activities (1 paper). The work is most often cited by research in Infectious Diseases (176 citations), Endocrinology (43 citations), Immunology (124 citations), Animal Science and Zoology (27 citations) and Biotechnology (22 citations). Patrick Cherubin has collaborated with scholars based in United States, Norway and Germany. Frequent co-authors include Ken Teter, Paul Bates, Michael J. Hogan, Florian Krammer, Katlyn Lederer, Diana Castaño, Drew Weissman, Thomas H. Oguin, Ivan Maillard and Steven H.Y. Fan. Their work appears in journals such as PLoS ONE, Scientific Reports, Immunity, Infection and Immunity and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.